Back
NYLI Candriam US Mid Cap Equity ETF Vs. Nebius Group NV Industry Stock Comparison
Buy
51
IQSM
NYLI Candriam US Mid Cap Equity ETF
Last Price:
$35.11
Seasonality Move:
1.31%
Sell
42
NBIS
Nebius Group NV
Last Price:
$89.47
Seasonality Move:
-2.57%
Buy
51
NYLI Candriam US Mid Cap Equity ETF (IQSM)
is a Buy
Is NYLI Candriam US Mid Cap Equity ETF a Buy, Sell or Hold?
-
The current NYLI Candriam US Mid Cap Equity ETF [IQSM] share price is $35.04. The Score for IQSM is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
IQSM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Nebius Group NV (NBIS)
is a Sell
Is Nebius Group NV a Buy, Sell or Hold?
-
The current Nebius Group NV [NBIS] share price is $89.46. The Score for NBIS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
NBIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IQSM Stock Price Chart
What is NYLI Candriam US Mid Cap Equity ETF's stock price today?
-
The NYLI Candriam US Mid Cap Equity ETF share price today is $35.04Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IQSM is experiencing slight buying pressure.
NBIS Stock Price Chart
What is Nebius Group NV's stock price today?
-
The Nebius Group NV share price today is $89.46Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIS is experiencing buying pressure, which is a positive indicator for future bullish movement.
IQSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.27 | Buy |
| Relative Strength Index (14 RSI): | 59.02 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.64 - 35.04) | Buy |
| Bollinger Bands (100): | (33.29 - 34.57) | Buy |
NBIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.05 | Sell |
| Relative Strength Index (14 RSI): | 47.32 | Sell |
| Chaikin Money Flow: | 13904832 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (83.34 - 98.02) | Sell |
| Bollinger Bands (100): | (72.32 - 115.66) | Sell |
IQSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.99 | Buy |
| 20-day SMA: | 34.64 | Buy |
| 50-day SMA: | 34.14 | Buy |
| 200-day SMA: | 32.57 | Buy |
| 8-day EMA: | 34.88 | Buy |
| 20-day EMA: | 34.63 | Buy |
| 50-day EMA: | 34.27 | Buy |
| 200-day EMA: | 33.23 | Buy |
NBIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.08 | Buy |
| 20-day SMA: | 91.37 | Sell |
| 50-day SMA: | 102.98 | Sell |
| 200-day SMA: | 65.21 | Buy |
| 8-day EMA: | 85.42 | Buy |
| 20-day EMA: | 90.53 | Sell |
| 50-day EMA: | 95.55 | Sell |
| 200-day EMA: | 73.6 | Buy |
NYLI Candriam US Mid Cap Equity ETF Earnings Growth & IQSM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nebius Group NV Earnings Growth & NBIS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.56 per share.
NYLI Candriam US Mid Cap Equity ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nebius Group NV Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||